Microorganisms within the gut and other niches may contribute to carcinogenesis, as well as
sha** cancer immunosurveillance and response to immunotherapy. Our understanding of …

Immunotherapy has revolutionized colon cancer treatment. Immune checkpoint inhibitors
(ICIs) have shown clinical benefits for colon cancer patients, especially those with high …

Probiotics and synbiotics are used to treat chronic illnesses due to their roles in immune
system modulation and anti-inflammatory response. They have been shown to reduce …

Although cancer immunotherapy has taken center stage in mainstream oncology inducing
complete and long-lasting tumor regression, only a subset of patients receiving treatment …

The human microbiome encodes more than three million genes, outnumbering human
genes by more than 100 times, while microbial cells in the human microbiota outnumber …

The gut microbiota influences anti-tumor immunity and can induce or inhibit response to
immune checkpoint inhibitors (ICIs). Therefore, microbiome features are being studied as …

Gut microbiome alterations are associated with various cancers including brain tumours
such as glioma and glioblastoma. The gut communicates with the brain via a bidirectional …

The immune system plays a key role in cancer suppression. Immunotherapy is widely used
as a treatment method in patients with various types of cancer. Immune checkpoint blockade …

The gut microbiota composition and dietary factors in our food along with the use of
prebiotics and probiotics play an important role in the maintenance of human health. A well …

BACKGROUND Emerging evidence links gut microbiota to various human diseases
including colorectal cancer (CRC) initiation and development. However, gut microbiota …